CLEAVAGE OF VASOACTIVE-INTESTINAL-PEPTIDE AT MULTIPLE SITES BY AUTOANTIBODIES

被引:0
|
作者
PAUL, S
MEI, S
MODY, B
EKLUND, SH
BEACH, CM
MASSEY, RJ
HAMEL, F
机构
[1] UNIV NEBRASKA, MED CTR, DEPT BIOCHEM, OMAHA, NE 68198 USA
[2] UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, OMAHA, NE 68198 USA
[3] IGEN INC, ROCKVILLE, MD 20852 USA
[4] UNIV KENTUCKY, MACROMOLEC ANAL FACIL, LEXINGTON, KY 40536 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasoactive intestinal peptide (VIP) fragments generated by autoantibodies purified from the blood of two human beings were separated and sequenced. Based on the identity of these fragments, seven peptide bonds cleaved by the antibodies were identified. Six of the seven scissile bonds are clustered in the region of VIP spanning residues 14-22 and were cleaved by antibodies from both human subjects. The seventh scissile bond is located at residues 7-8 and was cleaved by antibodies from one of the subjects. The scissile bonds link amino acid residues with different size, charge, and hydrophobicity. The hydrolytic activity of the antibodies was selective in that they failed to hydrolyze polypeptides unrelated in sequence to VIP (insulin and atrial natriuretic peptide). These observations demonstrate substrate specific hydrolysis by naturally occurring antibodies and expand the range of peptide bonds hydrolyzed by these antibodies.
引用
收藏
页码:16128 / 16134
页数:7
相关论文
共 50 条
  • [1] CATALYTIC AUTOANTIBODIES TO VASOACTIVE-INTESTINAL-PEPTIDE
    PAUL, S
    GAO, QS
    HUANG, H
    SUN, M
    THOMPSON, A
    RENNARD, S
    LANDERS, D
    CHEST, 1995, 107 (03) : S125 - S126
  • [2] VASOACTIVE-INTESTINAL-PEPTIDE
    SAID, SI
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1986, 9 (02) : 191 - 200
  • [3] VASOACTIVE-INTESTINAL-PEPTIDE - A CHRONOIMMUNOMODULATOR
    GUGINI, P
    LUCIA, P
    DIPALMA, L
    POZZILLI, P
    RE, M
    CANOVA, R
    GASBARRONE, L
    CIANETTI, A
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 46 (02): : 274 - 276
  • [4] TRANSMITTER ROLE OF VASOACTIVE-INTESTINAL-PEPTIDE
    FAHRENKRUG, J
    PHARMACOLOGY & TOXICOLOGY, 1993, 72 (06): : 354 - 363
  • [5] PULMONARY CLEARANCE OF VASOACTIVE-INTESTINAL-PEPTIDE
    BARROWCLIFFE, MP
    MORICE, A
    JONES, JG
    SEVER, PS
    THORAX, 1986, 41 (02) : 88 - 93
  • [6] VASOACTIVE-INTESTINAL-PEPTIDE AND NERVE REGENERATION
    RAYAN, GM
    SAID, SI
    CAHILL, SL
    DUKE, J
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1991, 16B (05): : 515 - 518
  • [7] VASOACTIVE-INTESTINAL-PEPTIDE IN THE HYPOTHALAMUS AND PITUITARY
    LAM, KSL
    NEUROENDOCRINOLOGY, 1991, 53 : 45 - 51
  • [8] VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR SCINTIGRAPHY
    VIRGOLINI, I
    KURTARAN, A
    RADERER, M
    LEIMER, M
    ANGELBERGER, P
    HAVLIK, E
    LI, SR
    SCHEITHAUER, W
    NIEDERLE, B
    VALENT, P
    EICHLER, HG
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (10) : 1732 - 1739
  • [9] VASOACTIVE-INTESTINAL-PEPTIDE AND INTRAOCULAR-PRESSURE - ADENYLATE-CYCLASE ACTIVATION AND BINDING-SITES FOR VASOACTIVE-INTESTINAL-PEPTIDE IN MEMBRANES OF OCULAR CILIARY PROCESSES
    MITTAG, TW
    TORMAY, A
    PODOS, SM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 241 (01): : 230 - 235
  • [10] SUPERACTIVE LIPOPHILIC PEPTIDES DISCRIMINATE MULTIPLE VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    GOZES, I
    LILLING, G
    GLAZER, R
    TICHER, A
    ASHKENAZI, IE
    DAVIDSON, A
    RUBINRAUT, S
    FRIDKIN, M
    BRENNEMAN, DE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (01): : 161 - 167